Hrt Financial LP Infinity Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.46 - $1.21 $5,216 - $13,721	11,340 New	11,340 $6,000
Q2 2022 Aug 12, 2022	BUY	$0.49 - $1.2 $9,797 - $23,994	19,995 New	19,995 $12,000
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $401,774 - $524,119	-151,043 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $299,065 - $809,590	151,043 New	151,043 $487,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.